Role of transition zone sampling by TURP in patients with raised PSA and multiple negative transrectal ultrasound-guided prostatic biopsies

Prostate Cancer and Prostatic Diseases

Volumn 7, Issue 4, 2004, Pages 338-342

  Radhakrishnan, Suresh ^a   Dorkin, T J ^a   Sheikh, N ^a   Greene, D R ^a  

^a SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

Transition zone cancers; Transurethral resection of prostate

Indexed keywords

GONADORELIN DERIVATIVE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; DIAGNOSTIC VALUE; ECHOGRAPHY; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE CARCINOMA; RETROSPECTIVE STUDY; SCORING SYSTEM; TRANSURETHRAL RESECTION; BIOPSY; BLOOD; ENDOSCOPIC ECHOGRAPHY; EPIDEMIOLOGY; LABORATORY DIAGNOSIS; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; FALSE NEGATIVE REACTIONS; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SAMPLING STUDIES; TRANSURETHRAL RESECTION OF PROSTATE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 16644364884     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500756     Document Type: Article

References (25)

1. Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: Update 1994. J Urol 1994; 152: 1358.
2. Catalona WJ et al. Comparison of digital rectal examination serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994; 151: 1283.
3. Djavan B et al. Safety morbidity of first repeat transrectal ultrasound guided prostate needle biopsies: Results of a prospective European prostate cancer detection study. J Urol 2001; 166: 856.
4. Djavan B et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: When should we stop? J urol 2001; 166: 1679.
5. Durkan GC, Greene DR. Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: Who should undergo a repeat biopsy? Br J Urol Int 1999; 83: 34.
6. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma: Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988; 12: 897.
7. Reissigl A et al. Frequency clinical significance of transition zone cancer in prostate cancer screening. Prostate 1997; 30: 130.
8. Stamey TA, Dietrick DD, Issa MM. Large organ confined impalpable transition zone prostate cancer: Association with metastatic levels of prostate specific antigen. J Urol 1993; 149: 510.
9. Coplen DE, Andriole GL, Yuan JJJ, Catalona WJ. The ability of systematic transrectal ultrasound guided biopsy to detect prostate cancer in men with the clinical diagnosis of benign prostatic hyperplasia. J Urol 1991; 146: 75.
10. Lee F et al. Prostate cancer: Transrectal ultrasound pathology comparison. A preliminary study of outer gland (peripheral and central zones) and inner gland (transition zone) cancer. Cancer 1991; 67 (Suppl. 4): 1132.
11. Hricak H. Advances in urologic imaging part 2: Prostate and bladder imaging. Monogr. Urol 1990; 11: 69.
12. Chang JJ, Shinohara K, Bhargava V, Presti JC. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 1998; 160: 2111.
13. McNeal JE et al. Stage A vs Stage B adenocarcinoma of the prostate: morphological comparison biological significance. J Urol 1988; 139: 61.
14. Ornstein DK, Rao GS, Smith DS, Andriole GL. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate. J Urol 1997; 157: 880.
15. Kitamura H et al. Does transurethral resection of the prostate facilitate detection of clinically significant prostate cancer that is missed with systematic sextant transition zone biopsies. Int J Urol 2002; 9: 95.
16. Zigeuner R et al. Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies. Urology 2003; 62: 883.
17. Lui PD, Terris MK, McNeal JE, Stamey TA. Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol 1995; 153: 1000.
18. Bazinet M et al. Value of systematic transition zone biopsies in the early detection of prostate cancer. J Urol Feb 1996; 155: 605.
19. Terris MK, Pham TQ, Issa MM, Kabalin JN. Routine transition zone seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J Urol 1997; 157: 204.
20. Durkan G, Sheik N, Hildreth AJ, Greene DR. Diagnostic yield of extended core biopsies of the lateral peripheral zone transition zone in the detection of prostate cancer. J Urol 2000; 163 (Suppl): 275.
21. Greene DR et al. A comparison of the morphological features of cancer arising in the transition zone in the peripheral zone of the prostate. J Urol 1991; 146: 1069.
22. Epstein JI, Paull G, Eggleston JC, Walsh PC. Prognosis of untreated stage A1 prostatic carcinoma: A study of 94 cases with extended follow up. J Urol 1986; 136: 837.
23. Neal DE, Habib F, Hargreave T. The National Prostatectomy Audit. Br J Uro l 1997; 79: 69.
24. Rovner ES, Schanne FJ, Malkowicz SB, Wein AJ. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies. J Urol 1997; 158: 138.
25. Bales GT et al. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia. Tech Urol 2000; 6: 201.